842 related articles for article (PubMed ID: 30949903)
1. Effects and Mechanism of Constitutive TL1A Expression on Intestinal Mucosal Barrier in DSS-Induced Colitis.
Yang M; Jia W; Wang D; Han F; Niu W; Zhang H; Shih DQ; Zhang X
Dig Dis Sci; 2019 Jul; 64(7):1844-1856. PubMed ID: 30949903
[TBL] [Abstract][Full Text] [Related]
2. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis.
Su L; Nalle SC; Shen L; Turner ES; Singh G; Breskin LA; Khramtsova EA; Khramtsova G; Tsai PY; Fu YX; Abraham C; Turner JR
Gastroenterology; 2013 Aug; 145(2):407-15. PubMed ID: 23619146
[TBL] [Abstract][Full Text] [Related]
3. Wogonoside alleviates colitis by improving intestinal epithelial barrier function via the MLCK/pMLC2 pathway.
Huang S; Fu Y; Xu B; Liu C; Wang Q; Luo S; Nong F; Wang X; Huang S; Chen J; Zhou L; Luo X
Phytomedicine; 2020 Mar; 68():153179. PubMed ID: 32062328
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor ligand-related molecule 1A affects the intestinal mucosal barrier function by promoting Th9/interleukin-9 expression.
Zhao C; Wang D; Wu M; Luo Y; Yang M; Guo J; Zhang H; Zhang X
J Int Med Res; 2020 Jun; 48(6):300060520926011. PubMed ID: 32567429
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 9-induced increase in intestinal epithelial tight junction permeability contributes to the severity of experimental DSS colitis.
Nighot P; Al-Sadi R; Rawat M; Guo S; Watterson DM; Ma T
Am J Physiol Gastrointest Liver Physiol; 2015 Dec; 309(12):G988-97. PubMed ID: 26514773
[TBL] [Abstract][Full Text] [Related]
6. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis.
Conlin VS; Wu X; Nguyen C; Dai C; Vallance BA; Buchan AM; Boyer L; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2009 Oct; 297(4):G735-50. PubMed ID: 19661153
[TBL] [Abstract][Full Text] [Related]
8. The effects and mechanisms of myeloid differentiation protein 2 on intestinal mucosal permeability in mice with chronic colitis.
Han C; Guan Q; Guo L; Yang Y; Ruan S; Zhang X
J Cell Physiol; 2019 Nov; 234(11):21089-21099. PubMed ID: 31032920
[TBL] [Abstract][Full Text] [Related]
9. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.
Zhao H; Zhang H; Wu H; Li H; Liu L; Guo J; Li C; Shih DQ; Zhang X
BMC Gastroenterol; 2012 May; 12():57. PubMed ID: 22647055
[TBL] [Abstract][Full Text] [Related]
10. AGR2 ameliorates tumor necrosis factor-α-induced epithelial barrier dysfunction via suppression of NF-κB p65-mediated MLCK/p-MLC pathway activation.
Ye X; Sun M
Int J Mol Med; 2017 May; 39(5):1206-1214. PubMed ID: 28339048
[TBL] [Abstract][Full Text] [Related]
11. Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis.
Mennigen R; Nolte K; Rijcken E; Utech M; Loeffler B; Senninger N; Bruewer M
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1140-9. PubMed ID: 19221015
[TBL] [Abstract][Full Text] [Related]
12. Aureusidin derivative CNQX inhibits chronic colitis inflammation and mucosal barrier damage by targeting myeloid differentiation 2 protein.
Yang Y; Sheng Y; Wang J; Zhou X; Guan Q; Shen H; Li W; Ruan S
J Cell Mol Med; 2021 Aug; 25(15):7257-7269. PubMed ID: 34184406
[TBL] [Abstract][Full Text] [Related]
13. Total polysaccharides of the Sijunzi decoction attenuate tumor necrosis factor-α-induced damage to the barrier function of a Caco-2 cell monolayer
Lu Y; Li L; Zhang JW; Zhong XQ; Wei JA; Han L
World J Gastroenterol; 2018 Jul; 24(26):2867-2877. PubMed ID: 30018481
[TBL] [Abstract][Full Text] [Related]
14. Somatostatin regulates tight junction proteins expression in colitis mice.
Li X; Wang Q; Xu H; Tao L; Lu J; Cai L; Wang C
Int J Clin Exp Pathol; 2014; 7(5):2153-62. PubMed ID: 24966923
[TBL] [Abstract][Full Text] [Related]
15. Chang'an II Decoction ( II )-Containing Serum Ameliorates Tumor Necrosis Factor-α-Induced Intestinal Epithelial Barrier Dysfunction via MLCK-MLC Signaling Pathway in Rats.
Chen T; Yin XL; Kang N; Wang XG; Li BS; Ji HJ; Zhang YQ; Bian LQ; Zhang BH; Wang FY; Tang XD
Chin J Integr Med; 2020 Oct; 26(10):745-753. PubMed ID: 31768870
[TBL] [Abstract][Full Text] [Related]
16. Dietary protocatechuic acid redistributes tight junction proteins by targeting Rho-associated protein kinase to improve intestinal barrier function.
So BR; Kim S; Jang SH; Kim MJ; Lee JJ; Kim SR; Jung SK
Food Funct; 2023 May; 14(10):4777-4791. PubMed ID: 37128780
[TBL] [Abstract][Full Text] [Related]
17.
Tan B; Luo W; Shen Z; Xiao M; Wu S; Meng X; Wu X; Yang Z; Tian L; Wang X
Scand J Gastroenterol; 2019 Apr; 54(4):432-440. PubMed ID: 30946611
[No Abstract] [Full Text] [Related]
18. Non-hematopoietic STAT6 induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis.
Lin Y; Li B; Yang X; Liu T; Shi T; Deng B; Zhang Y; Jia L; Jiang Z; He R
Mucosal Immunol; 2019 Nov; 12(6):1304-1315. PubMed ID: 31534167
[TBL] [Abstract][Full Text] [Related]
19. Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity.
Yu M; Wang Q; Ma Y; Li L; Yu K; Zhang Z; Chen G; Li X; Xiao W; Xu P; Yang H
Int J Biol Sci; 2018; 14(1):69-77. PubMed ID: 29483826
[TBL] [Abstract][Full Text] [Related]
20. Rebeccamycin Attenuates TNF-α-Induced Intestinal Epithelial Barrier Dysfunction by Inhibiting Myosin Light Chain Kinase Production.
Watari A; Sakamoto Y; Hisaie K; Iwamoto K; Fueta M; Yagi K; Kondoh M
Cell Physiol Biochem; 2017; 41(5):1924-1934. PubMed ID: 28391269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
